This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
Coldrex Now Available from Hemofarm
11. May 2021.
Hemofarm, which operates within STADA Group, expands its portfolio of Consumer Healthcare products in Serbia, and now offers Coldrex, one of a well-known products for relieving flue and cold symptoms. This product has previously been available in the markets of Central and Eastern Europe within the offer of GlaxoSmithKline, while in the future it will be a part of the STADA and Hemofarm product range.

During the previous period, STADA significantly expanded its operations in the field of OTC segment, including last year's acquisition of a part of the GlaxoSmithKline (GSK) portfolio, which was already present in many European countries, including Serbia. In addition to products intended for the treatment of cold and flu symptoms, this acquisition also included the takeover of GSK brands in the field of skin care, treatment of venous diseases, a range of products used for treating sore throat, etc. Coldrex portfolio that will be available in Serbia comprises several products in various forms: Coldrex HotRem Lemon in sachets, Coldrex MaxGrip Forest Fruit also in sachets, and Coldrex in the form of tablets.

Coldrex od sada u ponudi Hemofarma ‘The acquisition of established branded products from GSK has strengthened our position as a leading player in the global consumer healthcare segment. I am pleased that we are now officially taking over the marketing of these high-quality products in our core markets such as Serbia and are thus once again fulfilling our mission of caring for people's health as a trusted partner’, said STADA CEO Peter Goldschmidt.

According to Hemofarm’s CEO Ronald Seeliger, Hemofarm's already rich range of OTC products has now been further enhanced by the well-known Coldrex brand.

‘We have expanded our portfolio with another quality and well-known product in Serbia and region-wide, and we expect Coldrex, under our leadership, to maintain a high position among preparations indicated for relieving cold and flu symptoms. In addition to the fact that in the pandemic circumstances we are maximally focused on the production and regular supply of the market with medicinal products used in the treatment of COVID19 and chronic diseases, this is also an indicator of our commitment to simultaneous expanding the segment of CHC products for other milder indications. Besides launching new medicinal products and preparations, the development of our portfolio also includes taking over such products of other successful brands, while following the modern global therapeutic protocols’, the CEO of Hemofarm pointed out on this occasion.